Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.

Publication Year: 2022

DOI:
10.1007/s10620-022-07488-7

PMCID:
PMC9652190

PMID:
35366751

Journal Information

Full Title: Dig Dis Sci

Abbreviation: Dig Dis Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestsPkaazan, Z Tan, P Maiyani, M Mickenbecker, S Edwards & C McIvor: None. JM Andrews – Speaker’s fees, research support &/or Advisory Boards for Abbott, AbbVie, Allergan, Anatara, AstraZeneca, Bayer, BMS 2020, Celgene, Celltrion, Falk, Ferring, Gilead, Hospira, Immuninc, ImmunsanT, Janssen, MSD, Nestle, Novartis, Progenity, Pfizer, Sandoz, Shire, Takeda, Vifor, RAH research Fund, The Hospital Research Fund 2020–2022, The Helmsley Trust 2020–2023. Conflict of interests Pkaazan, Z Tan, P Maiyani, M Mickenbecker, S Edwards & C McIvor: None. JM Andrews – Speaker’s fees, research support &/or Advisory Boards for Abbott, AbbVie, Allergan, Anatara, AstraZeneca, Bayer, BMS 2020, Celgene, Celltrion, Falk, Ferring, Gilead, Hospira, Immuninc, ImmunsanT, Janssen, MSD, Nestle, Novartis, Progenity, Pfizer, Sandoz, Shire, Takeda, Vifor, RAH research Fund, The Hospital Research Fund 2020–2022, The Helmsley Trust 2020–2023."

Evidence found in paper:

"Funding Open Access funding enabled and organized by CAUL and its Member Institutions."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025